Skip to main content

Table 2 Association between CDK-based risk groups and clinicopathological parameters

From: Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

 

CDK1SA (cut-off = 12.6)

CDK2SA (cut-off = 222)

 

Low

High

Significance (Chi-square)

Low

High

Significance (Chi-square)

Sex

Male

57

49

 

76

30

 

Female

35

30

p =0.8817

55

10

p =0.0800

Age

< 70 years

43

40

 

66

17

 

≥ 70 years

49

39

p =0.7230

65

23

p =0.4888

Tumor size

≤ 3 cm

55

40

 

76

19

 

> 3 cm

37

39

p =0.2955

55

21

p =0.3223

pN

-

85

65

 

118

32

 

+

7

14

p =0.0759

13

8

p =0.1544

Stage

IA

53

36

 

73

16

 

IB

25

20

 

37

8

 

IIA

12

19

 

18

13

 

IIB

2

4

p =0.1652

3

3

p =0.0267

Histology

Adenocarcinoma

64

54

 

101

17

 

SCC

28

25

p =0.9961

30

23

p <0.0001

Facility

Tohoku Univ

53

37

 

72

18

 

Hyogo CC

39

42

p =0.2102

59

22

p =0.3557